Machina Capital S.A.S. purchased a new position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 9,127 shares of the medical research company’s stock, valued at approximately $2,043,000. Thermo Fisher Scientific makes up 1.3% of Machina Capital S.A.S.’s holdings, making the stock its 5th biggest holding.
A number of other large investors also recently modified their holdings of the stock. Mirae Asset Global Investments Co. Ltd. boosted its position in shares of Thermo Fisher Scientific by 11.6% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 39,954 shares of the medical research company’s stock worth $9,753,000 after buying an additional 4,137 shares in the last quarter. Ancora Advisors LLC purchased a new stake in shares of Thermo Fisher Scientific in the 3rd quarter worth about $166,000. GAM Holding AG boosted its position in shares of Thermo Fisher Scientific by 13.1% in the 3rd quarter. GAM Holding AG now owns 6,561 shares of the medical research company’s stock worth $1,602,000 after buying an additional 761 shares in the last quarter. Integrated Wealth Concepts LLC purchased a new stake in shares of Thermo Fisher Scientific in the 3rd quarter worth about $270,000. Finally, Tekla Capital Management LLC boosted its position in shares of Thermo Fisher Scientific by 18.1% in the 3rd quarter. Tekla Capital Management LLC now owns 180,395 shares of the medical research company’s stock worth $44,031,000 after buying an additional 27,700 shares in the last quarter. 88.66% of the stock is currently owned by institutional investors and hedge funds.
NYSE:TMO traded down $2.36 on Wednesday, reaching $261.56. The stock had a trading volume of 2,769,200 shares, compared to its average volume of 1,718,632. The firm has a market cap of $103.77 billion, a price-to-earnings ratio of 23.52, a price-to-earnings-growth ratio of 1.71 and a beta of 1.13. The company has a current ratio of 1.73, a quick ratio of 1.24 and a debt-to-equity ratio of 0.64. Thermo Fisher Scientific Inc. has a 12-month low of $202.83 and a 12-month high of $282.98.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, April 16th. Stockholders of record on Friday, March 15th were issued a dividend of $0.19 per share. This is a positive change from Thermo Fisher Scientific’s previous quarterly dividend of $0.17. This represents a $0.76 annualized dividend and a dividend yield of 0.29%. The ex-dividend date of this dividend was Thursday, March 14th. Thermo Fisher Scientific’s dividend payout ratio is presently 6.83%.
Several equities research analysts recently commented on TMO shares. UBS Group boosted their price objective on shares of Thermo Fisher Scientific to $305.00 and gave the stock a “buy” rating in a research report on Monday, March 25th. BTIG Research boosted their price objective on shares of Thermo Fisher Scientific to $290.00 and gave the stock a “buy” rating in a research report on Thursday, January 31st. Barclays upped their target price on shares of Thermo Fisher Scientific from $295.00 to $300.00 and gave the company an “overweight” rating in a report on Monday, March 18th. Needham & Company LLC assumed coverage on shares of Thermo Fisher Scientific in a report on Wednesday, January 2nd. They issued a “strong-buy” rating and a $271.00 target price on the stock. Finally, Zacks Investment Research lowered shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a report on Saturday, January 5th. Two investment analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company’s stock. Thermo Fisher Scientific has a consensus rating of “Buy” and a consensus target price of $293.33.
In related news, CAO Peter E. Hornstra sold 5,920 shares of the stock in a transaction that occurred on Friday, February 15th. The shares were sold at an average price of $250.00, for a total transaction of $1,480,000.00. Following the completion of the sale, the chief accounting officer now owns 17,057 shares of the company’s stock, valued at approximately $4,264,250. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Stephen Williamson sold 2,500 shares of the stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $266.00, for a total transaction of $665,000.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 36,927 shares of company stock worth $9,388,124. Insiders own 0.49% of the company’s stock.
WARNING: “Machina Capital S.A.S. Purchases New Position in Thermo Fisher Scientific Inc. (TMO)” was published by Baseball Daily News and is the sole property of of Baseball Daily News. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States and international copyright laws. The original version of this piece can be accessed at https://www.baseballdailydigest.com/news/2019/04/24/machina-capital-s-a-s-invests-2-04-million-in-thermo-fisher-scientific-inc-tmo-stock.html.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.
Read More: Asset Allocation
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.